cbdMD, Inc.
YCBD
$0.85
$0.011.59%
AMEX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -1.50% | -7.80% | -9.22% | -18.02% | -19.35% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -1.50% | -7.80% | -9.22% | -18.02% | -19.35% |
| Cost of Revenue | -3.53% | -2.18% | -8.37% | -12.93% | -18.43% |
| Gross Profit | -0.23% | -11.04% | -9.72% | -20.90% | -19.91% |
| SG&A Expenses | -9.74% | -18.41% | -25.60% | -28.41% | -28.23% |
| Depreciation & Amortization | -2.06% | -24.72% | -28.33% | -31.80% | -36.15% |
| Other Operating Expenses | 17.12% | -88.16% | -90.25% | -79.67% | -77.78% |
| Total Operating Expenses | -6.34% | -21.49% | -27.82% | -29.60% | -31.79% |
| Operating Income | 34.77% | 69.51% | 82.65% | 67.44% | 64.23% |
| Income Before Tax | 44.84% | 92.21% | 99.27% | 86.54% | 83.87% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 44.84% | 92.21% | 99.27% | 86.54% | 83.87% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 44.84% | 92.21% | 99.27% | 86.54% | 83.87% |
| EBIT | 34.77% | 69.51% | 82.65% | 67.44% | 64.23% |
| EBITDA | 52.14% | 85.26% | 98.01% | 78.56% | 71.00% |
| EPS Basic | 78.96% | 96.67% | 96.21% | 90.80% | 90.03% |
| Normalized Basic EPS | 88.28% | 96.01% | 94.58% | 86.07% | 85.09% |
| EPS Diluted | 78.96% | 96.67% | 96.22% | 90.80% | 90.03% |
| Normalized Diluted EPS | 88.28% | 96.01% | 94.58% | 86.07% | 85.09% |
| Average Basic Shares Outstanding | 649.51% | 515.06% | 136.73% | 143.97% | 182.81% |
| Average Diluted Shares Outstanding | 649.51% | 515.06% | 136.73% | 143.97% | 182.81% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |